Protease-activated receptors: sentries for inflammation?

By Cocks T.M.T.M.   Moffatt J.D.J.D.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 3, 2000-03 ,pp. : 103-108

Elsevier

Access to resources Recommend Favorite

Protease-Activated Receptors as Therapeutic Targets in Visceral Pain

By  

Current Neuropharmacology, Vol. 11, Iss. 6, 2013-12 ,pp. : 598-605

Bentham Science Publishers

Access to resources Recommend Favorite

The Multiple Layers of Signaling Selectivity at Protease-Activated Receptors

By  

Current Pharmaceutical Design, Vol. 18, Iss. 2, 2012-01 ,pp. : 161-174

Bentham Science Publishers

Access to resources Recommend Favorite

Protease-Activated Receptors (PARs) are Partly Pro-Inflammatory and Partly Anti-Inflammatory: Will PAR Agonists or Antagonists Participate in Future Drug Therapies?

By  

Current Drug Targets, Vol. 7, Iss. 5, 2006-05 ,pp. : 629-637

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological characterization of protease-activated receptor (PAR-1) in rat astrocytes

By Debeir T.   Vige X.   Benavides J.  

European Journal of Pharmacology, Vol. 323, Iss. 1, 1997-03 ,pp. : 111-117

Elsevier

Access to resources Recommend Favorite